Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
LFMD - LifeMD Inc - Stock Price Chart
TickerLFMD [NASD]
CompanyLifeMD Inc
CountryUSA
IndustryHealth Information Services
Market Cap351.43MEPS (ttm)-0.75
P/E-EPS this Y58.86%
Forward P/E62.95EPS next Y145.83%
PEG-EPS past 5Y-25.48%
P/S2.15EPS next 5Y-
P/B-EPS Q/Q-27.35%
Dividend-Sales Q/Q33.26%
Insider Own22.70%Inst Own31.19%
Insider Trans0.00%Inst Trans-2.04%
Short Float7.84%EarningsMay 08/a
Analyst Recom1.00Target Price13.00
Avg Volume755.39K52W Range1.72 - 12.88
May-09-24 11:46AM LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript (Insider Monkey) -24.57%
May-08-24 09:58PM LFMD Stock Earnings: LifeMD Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance (GlobeNewswire)
May-02-24 08:00AM LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition (GlobeNewswire) +7.30%
May-01-24 09:40AM Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 08:00AM LifeMD Appoints Dr. Calum MacRae to its Board of Directors (GlobeNewswire)
Apr-24-24 08:00AM LifeMD to Report First Quarter 2024 Financial Results on May 8 (GlobeNewswire)
Apr-23-24 08:00AM LifeMD to Participate in Upcoming Investor and Industry Conferences During May (GlobeNewswire) +8.90%
Mar-26-24 08:00AM LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-25-24 08:00AM LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
MRSN - Mersana Therapeutics Inc - Stock Price Chart
TickerMRSN [NASD, RUT]
CompanyMersana Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap314.47MEPS (ttm)-1.14
P/E-EPS this Y58.18%
Forward P/E-EPS next Y-16.36%
PEG-EPS past 5Y11.93%
P/S8.21EPS next 5Y-
P/B11.24EPS Q/Q69.56%
Dividend-Sales Q/Q18.50%
Insider Own24.18%Inst Own68.33%
Insider Trans-0.22%Inst Trans4.06%
Short Float11.77%EarningsMay 09/b
Analyst Recom1.44Target Price6.38
Avg Volume2.22M52W Range0.80 - 9.62
May-10-24 04:36PM Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript (Insider Monkey) +9.94%
03:15PM Mersana Therapeutics Inc (MRSN) Reports Q1 2024 Financial Results: A Detailed Analysis (GuruFocus.com)
May-09-24 11:55AM MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) -27.50%
08:05AM Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:59AM Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results (GlobeNewswire)
May-03-24 04:30PM Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-02-24 08:00AM Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024 (GlobeNewswire)
Apr-04-24 04:30PM Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 08:41AM Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript (Insider Monkey) +12.16%
Feb-28-24 09:49PM Q4 2023 Mersana Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +13.58%
INO - Inovio Pharmaceuticals Inc - Stock Price Chart
TickerINO [NASD]
CompanyInovio Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap338.64MEPS (ttm)-5.53
P/E-EPS this Y27.34%
Forward P/E-EPS next Y27.98%
PEG-EPS past 5Y13.49%
P/S470.34EPS next 5Y41.50%
P/B3.23EPS Q/Q30.69%
Dividend-Sales Q/Q-100.00%
Insider Own0.77%Inst Own16.59%
Insider Trans0.00%Inst Trans48.33%
Short Float7.89%EarningsMay 13/a
Analyst Recom2.00Target Price18.92
Avg Volume440.24K52W Range3.89 - 14.75
May-14-24 08:21AM Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:55AM Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target (MT Newswires)
03:02AM Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 09:45PM Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript (Motley Fool) +6.67%
08:55PM INO Stock Earnings: Inovio Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
04:28PM Inovio: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights (PR Newswire)
May-05-24 08:54AM This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy? (Motley Fool)
May-01-24 08:00AM INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Apr-29-24 08:00AM INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 (PR Newswire) +8.80%
WINT - Windtree Therapeutics Inc - Stock Price Chart
TickerWINT [NASD]
CompanyWindtree Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.33MEPS (ttm)-146.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y66.05%
P/S-EPS next 5Y-
P/B0.45EPS Q/Q93.15%
Dividend-Sales Q/Q-
Insider Own16.82%Inst Own2.93%
Insider Trans0.00%Inst Trans-
Short Float3.02%EarningsApr 17/b
Analyst Recom3.00Target Price18.00
Avg Volume23.55K52W Range3.72 - 35.10
May-07-24 08:00AM Windtree Therapeutics Regains Compliance with Nasdaq (GlobeNewswire) -9.74%
Apr-18-24 08:00AM Windtree Therapeutics Announces Reverse Stock Split (GlobeNewswire) -15.32%
Apr-17-24 08:00AM Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates (GlobeNewswire)
06:52AM WINT Stock Earnings: Windtree Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
Apr-08-24 04:48PM Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing (GlobeNewswire)
Feb-01-24 08:00AM Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research (GlobeNewswire)
Jan-31-24 08:00AM Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives (GlobeNewswire) -6.60%
Jan-26-24 09:20AM Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company (ACCESSWIRE)
Jan-25-24 08:30AM Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company (GlobeNewswire)
Jan-18-24 09:00AM Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China (ACCESSWIRE)
ADIL - Adial Pharmaceuticals Inc - Stock Price Chart
TickerADIL [NASD]
CompanyAdial Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.75MEPS (ttm)-5.88
P/E-EPS this Y35.83%
Forward P/E-EPS next Y30.95%
PEG-EPS past 5Y38.36%
P/S-EPS next 5Y-
P/B0.94EPS Q/Q20.13%
Dividend-Sales Q/Q-
Insider Own6.78%Inst Own7.75%
Insider Trans0.00%Inst Trans-
Short Float4.42%EarningsNov 14/b
Analyst Recom1.67Target Price7.50
Avg Volume6.40M52W Range0.76 - 14.00
Today 09:54AM ADIL Stock Earnings: Adial Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
08:30AM Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-22-24 10:00AM EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent (Benzinga)
08:30AM Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office (GlobeNewswire)
Apr-10-24 11:53AM Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today? (InvestorPlace) +106.19%
08:30AM Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder (GlobeNewswire)
Apr-02-24 08:30AM Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update (GlobeNewswire)
Mar-01-24 07:00PM Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds (GlobeNewswire) +59.80%
Feb-28-24 09:30AM Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office (GlobeNewswire) +85.50%
Feb-15-24 09:00AM Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20 (ACCESSWIRE)
HTZ - Hertz Global Holdings Inc. - Stock Price Chart
TickerHTZ [NASD]
CompanyHertz Global Holdings Inc.
CountryUSA
IndustryRental & Leasing Services
Market Cap778.82MEPS (ttm)0.62
P/E8.87EPS this Y-456.87%
Forward P/E31.41EPS next Y109.22%
PEG-EPS past 5Y-
P/S0.08EPS next 5Y-
P/B0.60EPS Q/Q-200.49%
Dividend-Sales Q/Q1.61%
Insider Own2.89%Inst Own-
Insider Trans6.48%Inst Trans-6.46%
Short Float23.71%EarningsApr 25/b
Analyst Recom3.33Target Price5.26
Avg Volume6.47M52W Range4.35 - 19.36
Today 12:27PM Used car prices fall again in April, down nearly 17% from pandemic highs (Yahoo Finance) -8.67%
06:04AM Why the 2024 meme stock action is much tamer than 2021 so far (Yahoo Finance)
May-14-24 03:18AM Heard on the Street Monday Recap: Hello Kitty (The Wall Street Journal) +9.69%
May-13-24 11:21AM Meme Stocks Jump Alongside GameStop After 'Roaring Kitty' Post (The Wall Street Journal) +11.86%
May-12-24 03:24PM 5 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
Apr-30-24 04:00AM Bear of the Day: Hertz (HTZ) (Zacks)
Apr-25-24 06:02PM Hertz Stock Plunges 19% as It Continues to Lose Money on Ill-Fated Tesla EV Plan (Investopedia) -19.31%
01:27PM Hertz loses another $200 million from its EVs (Yahoo Finance)
11:53AM HTZ Stock Earnings: Hertz Global Holdings Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
10:30AM Compared to Estimates, Hertz Global (HTZ) Q1 Earnings: A Look at Key Metrics (Zacks)
DHC - Diversified Healthcare Trust - Stock Price Chart
TickerDHC [NASD, RUT]
CompanyDiversified Healthcare Trust
CountryUSA
IndustryREIT - Healthcare Facilities
Market Cap572.13MEPS (ttm)-1.37
P/E-EPS this Y6.88%
Forward P/E-EPS next Y27.62%
PEG-EPS past 5Y-
P/S0.40EPS next 5Y3.20%
P/B0.25EPS Q/Q-63.39%
Dividend1.68%Sales Q/Q7.15%
Insider Own10.32%Inst Own74.54%
Insider Trans0.00%Inst Trans-2.21%
Short Float3.42%EarningsMay 06/a
Analyst Recom3.00Target Price3.50
Avg Volume1.12M52W Range0.85 - 3.96
May-06-24 04:15PM Diversified Healthcare Trust Announces First Quarter 2024 Results (Business Wire)
May-02-24 08:00AM Diversified Healthcare Trust Provides Monthly SHOP Performance Update (Business Wire)
Apr-16-24 08:00AM The RMR Group Highlights Recent Achievements in 2023 Annual Sustainability Report (Business Wire) -7.09%
Apr-11-24 08:00AM Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares (Business Wire)
Apr-08-24 08:00AM Diversified Healthcare Trust First Quarter 2024 Conference Call Scheduled for Tuesday, May 7th (Business Wire)
Apr-02-24 04:15PM Diversified Healthcare Trust Provides Monthly SHOP Performance Update (Business Wire)
Feb-26-24 04:15PM Diversified Healthcare Trust Provides Monthly SHOP Performance Update (Business Wire)
04:15PM Diversified Healthcare Trust Announces Fourth Quarter 2023 Results (Business Wire)
Jan-31-24 08:00AM Diversified Healthcare Trust Provides Monthly SHOP Performance Update (Business Wire) -5.90%
Jan-29-24 08:00AM Diversified Healthcare Trust Fourth Quarter 2023 Conference Call Scheduled for Tuesday, February 27th (Business Wire)
ENTX - Entera Bio Ltd - Stock Price Chart
TickerENTX [NASD]
CompanyEntera Bio Ltd
CountryIsrael
IndustryBiotechnology
Market Cap92.96MEPS (ttm)-0.29
P/E-EPS this Y19.35%
Forward P/E-EPS next Y-116.00%
PEG-EPS past 5Y25.05%
P/S-EPS next 5Y-
P/B10.50EPS Q/Q27.76%
Dividend-Sales Q/Q-
Insider Own20.07%Inst Own12.07%
Insider Trans0.92%Inst Trans-4.02%
Short Float0.12%EarningsMay 10/a
Analyst Recom1.00Target Price10.00
Avg Volume262.55K52W Range0.52 - 3.35
Today 08:00AM Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member (GlobeNewswire)
May-13-24 07:00AM Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024 (GlobeNewswire)
May-10-24 08:53PM ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024 (InvestorPlace)
04:10PM Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-26-24 06:00PM Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Apr-18-24 06:15PM Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today (Zacks)
Apr-15-24 03:43PM Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? (InvestorPlace) -15.44%
Apr-12-24 09:40AM Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? (Zacks) +12.03%
Apr-09-24 09:09AM Here's Why You Should Invest in Entera Bio (ENTX) Stock Now (Zacks) +15.38%
Apr-08-24 08:30AM Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research (GlobeNewswire)
BTOC - Armlogi Holding Corp. - Stock Price Chart
TickerBTOC [NASD]
CompanyArmlogi Holding Corp.
CountryUSA
IndustryIntegrated Freight & Logistics
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.32M52W Range4.14 - 6.26
Today 04:05PM Armlogi Holding Corp. Announces Closing of $8 Million Initial Public Offering (GlobeNewswire)
May-14-24 01:35PM Armlogi Shares Fall in Nasdaq Debut (MT Newswires)
12:50PM ARMLOGI HOLDING CORP. Announces Pricing of $8 Million Initial Public Offering (ACCESSWIRE)
10:30AM ARMLOGI, consulted by ATIF, successfully listed on Nasdaq (PR Newswire)
May-13-24 06:00PM ARMLOGI HOLDING CORP. ANNOUNCES PRICING OF $8 MILLION INITIAL PUBLIC OFFERING (GlobeNewswire)
GFAI - Guardforce AI Co Ltd - Stock Price Chart
TickerGFAI [NASD]
CompanyGuardforce AI Co Ltd
CountrySingapore
IndustrySecurity & Protection Services
Market Cap29.78MEPS (ttm)-12.16
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.83EPS next 5Y-
P/B0.83EPS Q/Q39.19%
Dividend-Sales Q/Q8.68%
Insider Own22.46%Inst Own1.41%
Insider Trans0.00%Inst Trans-58.46%
Short Float8.64%Earnings-
Analyst Recom1.00Target Price9.00
Avg Volume444.44K52W Range2.04 - 9.90
Today 09:00AM Guardforce AI Launches AI Robotic Solution 'LinguaBot' Through Strategic Partnership with iApp Technology (GlobeNewswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
09:00AM Guardforce AI Reports Record Revenue of $36.3 Million for 2023 (GlobeNewswire)
Apr-17-24 07:00AM Guardforce to Present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024 (ACCESSWIRE)
Jan-17-24 07:00AM Guardforce AI Appoints Yuting Zuo as Chief Financial Officer (GlobeNewswire)
Oct-24-23 08:00AM Guardforce AI Completes Conversion of $15.91 Million of Total Debt and Interest into Ordinary Shares at $5.40 Per Share (GlobeNewswire) +11.04%
Oct-19-23 03:07PM 3 Stocks Poised for a Short Squeeze Rally (InvestorPlace)
Oct-17-23 10:42AM GFAI Stock Alert: Guardforce AI Announces New 3-Year Contract (InvestorPlace)
07:00AM Guardforce AI Has Secured a Three-Year Contract with a Leading Japanese Retailer for its End-to-End Cash Management Solution Including Guardforce Digital Machine in Thailand (GlobeNewswire)
Oct-02-23 07:00AM Guardforce AI Reports Interim Financial Results for the First Half of 2023, and Provides Business Update (GlobeNewswire)
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.